A detailed history of Lord, Abbett & Co. LLC transactions in Mckesson Corp stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 199,136 shares of MCK stock, worth $115 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
199,136
Previous 199,136 -0.0%
Holding current value
$115 Million
Previous $98.5 Million -0.0%
% of portfolio
0.31%
Previous 0.32%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$479.06 - $630.38 $53.6 Million - $70.5 Million
111,808 Added 128.03%
199,136 $98.5 Million
Q2 2024

Oct 07, 2024

BUY
$518.81 - $607.81 $2.22 Million - $2.6 Million
4,272 Added 5.14%
87,328 $51 Million
Q2 2024

Aug 14, 2024

BUY
$518.81 - $607.81 $2.22 Million - $2.6 Million
4,272 Added 5.14%
87,328 $51 Million
Q1 2024

Oct 07, 2024

BUY
$473.42 - $539.26 $799,606 - $910,810
1,689 Added 2.08%
83,056 $44.6 Million
Q1 2024

May 09, 2024

BUY
$473.42 - $539.26 $799,606 - $910,810
1,689 Added 2.08%
83,056 $44.6 Million
Q4 2023

Oct 07, 2024

SELL
$437.42 - $470.64 $4.43 Million - $4.77 Million
-10,131 Reduced 11.07%
81,367 $37.7 Million
Q4 2023

Feb 12, 2024

SELL
$437.42 - $470.64 $4.43 Million - $4.77 Million
-10,131 Reduced 11.07%
81,367 $37.7 Million
Q3 2023

Oct 07, 2024

SELL
$402.4 - $446.42 $378,256 - $419,634
-940 Reduced 1.02%
91,498 $39.8 Million
Q3 2023

Nov 13, 2023

SELL
$402.4 - $446.42 $378,256 - $419,634
-940 Reduced 1.02%
91,498 $39.8 Million
Q2 2023

Oct 07, 2024

SELL
$354.01 - $427.31 $347,991 - $420,045
-983 Reduced 1.05%
92,438 $39.5 Million
Q2 2023

Aug 14, 2023

SELL
$354.01 - $427.31 $347,991 - $420,045
-983 Reduced 1.05%
92,438 $39.5 Million
Q1 2023

Oct 07, 2024

SELL
$335.35 - $386.06 $7.78 Million - $8.95 Million
-23,185 Reduced 19.88%
93,421 $33.3 Million
Q1 2023

May 12, 2023

SELL
$335.35 - $386.06 $7.78 Million - $8.95 Million
-23,185 Reduced 19.88%
93,421 $33.3 Million
Q4 2022

Oct 07, 2024

BUY
$346.68 - $397.58 $10.2 Million - $11.6 Million
29,278 Added 33.53%
116,606 $43.7 Million
Q4 2022

Feb 10, 2023

SELL
$346.68 - $397.58 $6.43 Million - $7.37 Million
-18,548 Reduced 13.72%
116,606 $43.7 Million
Q3 2022

Nov 14, 2022

BUY
$321.25 - $373.84 $2.47 Million - $2.87 Million
7,681 Added 6.03%
135,154 $45.9 Million
Q2 2022

Aug 12, 2022

SELL
$300.57 - $336.42 $1.03 Million - $1.15 Million
-3,417 Reduced 2.61%
127,473 $41.6 Million
Q1 2022

May 13, 2022

SELL
$244.61 - $310.48 $25.3 Million - $32.1 Million
-103,355 Reduced 44.12%
130,890 $40.1 Million
Q4 2021

Feb 11, 2022

SELL
$198.21 - $248.9 $3.87 Million - $4.86 Million
-19,532 Reduced 7.7%
234,245 $58.2 Million
Q3 2021

Nov 09, 2021

SELL
$188.42 - $208.66 $1.81 Million - $2.01 Million
-9,614 Reduced 3.65%
253,777 $50.6 Million
Q2 2021

Aug 11, 2021

SELL
$184.89 - $202.68 $4.8 Million - $5.26 Million
-25,967 Reduced 8.97%
263,391 $50.4 Million
Q1 2021

May 11, 2021

BUY
$169.52 - $196.53 $2.09 Million - $2.42 Million
12,323 Added 4.45%
289,358 $56.4 Million
Q4 2020

Feb 09, 2021

BUY
$143.79 - $183.66 $3.11 Million - $3.97 Million
21,620 Added 8.46%
277,035 $48.2 Million
Q3 2020

Nov 12, 2020

SELL
$140.89 - $159.9 $5.78 Million - $6.56 Million
-41,034 Reduced 13.84%
255,415 $38 Million
Q2 2020

Aug 14, 2020

BUY
$125.49 - $164.68 $5.19 Million - $6.81 Million
41,358 Added 16.21%
296,449 $45.5 Million
Q1 2020

May 14, 2020

BUY
$115.75 - $170.96 $2.57 Million - $3.8 Million
22,205 Added 9.53%
255,091 $34.5 Million
Q4 2019

Feb 14, 2020

SELL
$130.23 - $153.27 $9.96 Million - $11.7 Million
-76,446 Reduced 24.71%
232,886 $32.2 Million
Q3 2019

Nov 14, 2019

BUY
$134.24 - $148.53 $279,353 - $309,090
2,081 Added 0.68%
309,332 $42.3 Million
Q2 2019

Aug 14, 2019

BUY
$112.47 - $134.93 $34.6 Million - $41.5 Million
307,251 New
307,251 $41.3 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $83.2B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.